Akebia Therapeutics Inc. (AKBA) surged 6.08% or 0.48 to $8.37. It is near to 302632 shares traded, which is 59.7% compare to the average total volume 506939. The market cap of AKBA is $477.47 million. The year to date change is -41.21%. The 52 week price range is from $7.42 to $20.25. Price of AKBA have changed 3.95% during last week. It have changed -23.62% over last month, -24.28% over last 3 months, -44.86% over last 6 months and -47.26% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKBA is 9.89. It is 18.16% above current price. The 200-day Moving Averages for AKBA is 12.27. It is 46.59% above current price. The 52-week High is 20.25. It is 141.94% from the current price. The 52-week Low is 7.42. It is -11.35% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of AKBA is 5.14 on 2018-07-31. Short % to float is 5.23%. There are some statistics of AKBA. It is has market cap $477.47 million. The share outstanding is 57.05 million. The average volume is 506939. The revenue is 41.28M. The percent of top 15 Institution holding is 80.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKBA is -61.31%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKBA is -18.21%.